Is Verano Holdings stock a buy right now?

Haywood analyst Neal Gilmer maintained a “Buy” rating and $3.75 target on Verano Holdings (Verano Holdings Stock Quote, Chart, News, Analysts, Financials CBOE:VRNO) after first-quarter 2026 results came in ahead of his revenue expectations.

“Verano announced Q1/26 results that showed surprising revenue growth in a typically softer quarter on a seasonal basis,” Gilmer said on April 30, noting revenue was 5% above his estimate.

Verano reported revenue of $208.2-million, ahead of Gilmer’s $198.3-million estimate and consensus at $200.6-million. Gross margin was 47.5%, below his 49.5-per-cent estimate and down from 51.2%in the prior quarter. Adjusted EBITDA was $49.0-million, slightly below his $50.0-million estimate and consensus at $51.3-million.

Gilmer said management pointed to promotional activity and inventory movements as reasons for the margin dip. Verano generated $18.6-million in operating cash flow and ended the quarter with $74.0-million in cash and total debt of $394.9-million, excluding leases.

The company opened two Florida dispensaries during the quarter and another after quarter-end, bringing its Florida total to 85 and its national footprint to 162 stores. Verano also announced a share repurchase program of up to $20-million.

“Verano is executing on its objectives and has runway for growth going forward with a focus on cash flow generation in 2026,” Gilmer said.

Gilmer raised his 2026 revenue estimate after the first-quarter beat but lowered EBITDA slightly on more conservative margin assumptions. He expects Verano to generate Adjusted EBITDA of $228.4-million on revenue of $847.4-million in fiscal 2026, improving to $243.6-million on revenue of $863.3-million in fiscal 2027.

 

-30-

Tagged with: vrno
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

15 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

15 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

15 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

15 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

15 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

15 hours ago